Ann Dermatol.  2014 Dec;26(6):789-790. 10.5021/ad.2014.26.6.789.

Non-Eczematous Vesiculobullous Skin Eruption after Stevens-Johnson Syndrome: Developed without Intravenous Immunoglobulin Therapy

• Kim JA
• Kim M
• Cho BK
• Park HJ

• KMID: 2264891
• DOI: http://doi.org/10.5021/ad.2014.26.6.789

Abstract

No abstract available.

MeSH Terms

Immunization, Passive*
Skin*
Stevens-Johnson Syndrome*

Figure

• 

  Fig. 1 Asymptomatic multiple clear vesicles on the palms.

• 

  Fig. 2 (A, B) The biopsy specimen showed an intracorneal vesicle with hyperkeratosis and acanthosis with mild lymphocytic infiltration in the papillary dermis (H&E; A: ×40, B: ×200).

Reference

1. Wollina U. Pompholyx: what's new? Expert Opin Investig Drugs. 2008; 17:897–904.

2. Cohen Aubart F, Barete S, Amoura Z, Francès C, Lyon-Caen O, Lebrun-Vignes B. Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study. Eur J Intern Med. 2009; 20:70–73.

3. Gerstenblith MR, Antony AK, Junkins-Hopkins JM, Abuav R. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy. J Am Acad Dermatol. 2012; 66:312–316.

4. Young PK, Ruggeri SY, Galbraith S, Drolet BA. Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome. Arch Dermatol. 2006; 142:247–248.

5. Lin WL, Lin WC, Chang YC, Yang LC, Hung SI, Hong HS, et al. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome. Am J Clin Dermatol. 2009; 10:339–342.